Replies to post #80199 on Creative Medical Technology Holdings Inc (CELZ)

[Auri12in]

Depending on when you spoke with that lady, many of the procedures may have been performed in q1

[uvaphd]

+100

Nothing new—they’ve been PRESENTING themselves as operating with abundant amounts of snakeoil and subterfuge for over a year now. If they wish to change that perception of themselves, they could do so VERY easily and safely. In the meantime, we have a modern day version of the Delphic Oracle—where is the Sibyl when we need her?

[Gobsmacked01]

$1600 per kit / procedure is a number it seems we can work with.

Hmmm, Doing 3 procedures in the morning, 3 procedures in the afternoon and only on Tuesdays and Thursday yields 12 procedures per week.

52 weeks in the year yields 52X12= 624 procedures per clinic per year.
Ignoring all international yield, signing 1 clinic per state this year yields 50X624= 31,200 procedures per year in the US alone. CELZ doesn't bear the cost of opening or running any of the clinics.

31200X$1600 = $49.9 Milly per year.

How hard is it to sign on 50 clinics by end of 2019; scheduling procedures enough to keep 1 doctor busy for 2 days of the week?
March 28, 2019 shareholder update:

We have added physicians in Hawaii, California, Ohio, Texas and Tennessee

- California, for example, could be multiple new clinics.
We seem to have added at least 5 clinics in Q4 2018 / Q1 2019 bringing us to at least 14 clinics and leaving 36 more to go or so. Kind of a slow start.... but:

In order to properly train each physician, we require a minimum of 5 patients. This requires scheduling all patients, the physician and our trainer. This process has caused delays, therefore we have added additional medical personnel to travel to each physicians office to train. With this increased flexibility on our part we anticipate a reduction in such delays.

Reducing delays successfully translates to signing greater numbers of clinics per quarter. It seems reasonable to me for domestic traffic alone to position this ticker by end of 2019 with an annual revenue of $50 milly.

Italy already has a doctor onboard and other global entities could accelerate this growth with news this year (Germany, France, Swiss, Russia). Partnering or associating with an established stem cell clinic network domestically could also accelerate this expansion.

Q1 2019 will tell more of the tale, but imo she is a 50 milly MC minimum sometime this year yielding about a .05 PPS based on current roughly 1 billy OS. At these prices, could this ticker be a 5 bagger for a new investor soon, as in within the next quarter?

-Go CELZ$$$$